MC-19PD1 CAR-T in Relapsed or Refractory B Cell Lymphoma
Clinical trial NCT03932955 · UNKNOWN
Trial details
- NCT number
- NCT03932955
- Sponsor
- Peking University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-05-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.